New Test Assesses Individual Breast Cancer Risk
MONDAY, Oct. 5 (HealthDay News) — Analyzing individual breast tissue for specific structural characteristics may more precisely determine a woman’s risk for developing breast cancer.
In the Oct. 5 online issue of the Journal of Clinical Oncology, researchers report that the more acini a woman has — these are the sacs that produce milk — and the larger her breast lobules, the higher the chance she will get breast cancer.
“A tremendous number of women get breast biopsies from abnormal mammograms. They number 1 to 2 million people a year in the U.S. alone,” said study co-author Derek Radisky, an assistant professor of biochemistry at the Mayo Clinic in Jacksonville, Fla. “Of these, about one-quarter have positive findings of cancer while the rest could immediately benefit from this kind of assessment.”
“We have recognized for a long time that the cancer risk-assessment models we have are not perfect, particularly for individual patients, so certainly this is an approach that’s very interesting. But it’s not going to change anything for a woman who walks in the clinic for the next year,” said Dr. Angela Bradbury, director of the Margaret Dyson Family Risk Assessment Program at Fox Chase Cancer Center in Philadelphia. “But it’s exactly this type of paper, this type of research that, two to three years down the road, may actually play out in the clinic. Anything that improves on our risk assessment will be useful.”
Currently, factors such as family history of breast cancer, number of pregnancies and age at first pregnancy are helpful in predicting how often breast cancer will arise in a larger population.
But these same tools are poor indicators of individual risk.
“They’re terrible on an individual basis, so there’s no individualized ability to say whether a person is likely to get cancer or not,” Radisky said.
Other than family history and genetics, the best tool experts have to predict individual breast cancer risk is the Gail model, which takes into account age and number of previous biopsies, as well as family history and pregnancy history.
But, the authors stated, the Gail model is “only slightly better than chance alone.”
This is not the case in cervical or colon cancer, where pathologists can tell from physical characteristics of actual tissue how likely a person is to get that type of cancer.
Breast cancer originates in the breast lobules. The lobules are supposed to disappear as a woman ages, reducing her breast cancer risk, but this doesn’t always happen.
The authors analyzed tissue from 85 women with breast cancer (as well as earlier tissue samples taken before they developed the cancer) and 142 control samples from women who had had benign breast disease.
The more acini per lobule a woman had and the larger the lobule, the higher her risk for developing breast cancer, the researchers found.
This new technique proved more accurate than the Gail model.
The study was a relatively small one by breast cancer standards. More research will not only have to have more women, it will also need to incorporate additional risk factors and will need to be tested in a separate set of women, Radisky said.
Still, he said, the current results “look very good” and he would be “pretty shocked if [more findings] were not consistent.”
If more studies do replicate these initial findings, the procedure might find its way into clinical practice fairly easily and quickly.
“That’s the real power of this. It’s not high tech. It could be done anywhere that takes tissue and has a microscope,” Radisky said. “It could be done anywhere once we build the model, using factors that are available to the physician just from asking the patient and taking tissue, which could be evaluated by any pathologist in any town in America.”
More information
The American Cancer Society has more on risk factors for breast cancer.
By Amanda Gardner
HealthDay Reporter
SOURCES: Derek Radisky, Ph.D., assistant professor, biochemistry, Mayo Clinic, Jacksonville, Fla.; Angela Bradbury, M.D., director, Margaret Dyson Family Risk Assessment Program, Fox Chase Cancer Center, Philadelphia; Oct. 5, 2009, Journal of Clinical Oncology, online
MONDAY, Oct. 5 (HealthDay News) — Analyzing individual breast tissue for specific structural characteristics may more precisely determine a woman’s risk for developing breast cancer.
In the Oct. 5 online issue of the Journal of Clinical Oncology, researchers report that the more acini a woman has — these are the sacs that produce milk — and the larger her breast lobules, the higher the chance she will get breast cancer.
“A tremendous number of women get breast biopsies from abnormal mammograms. They number 1 to 2 million people a year in the U.S. alone,” said study co-author Derek Radisky, an assistant professor of biochemistry at the Mayo Clinic in Jacksonville, Fla. “Of these, about one-quarter have positive findings of cancer while the rest could immediately benefit from this kind of assessment.”
“We have recognized for a long time that the cancer risk-assessment models we have are not perfect, particularly for individual patients, so certainly this is an approach that’s very interesting. But it’s not going to change anything for a woman who walks in the clinic for the next year,” said Dr. Angela Bradbury, director of the Margaret Dyson Family Risk Assessment Program at Fox Chase Cancer Center in Philadelphia. “But it’s exactly this type of paper, this type of research that, two to three years down the road, may actually play out in the clinic. Anything that improves on our risk assessment will be useful.”
Currently, factors such as family history of breast cancer, number of pregnancies and age at first pregnancy are helpful in predicting how often breast cancer will arise in a larger population.
But these same tools are poor indicators of individual risk.
“They’re terrible on an individual basis, so there’s no individualized ability to say whether a person is likely to get cancer or not,” Radisky said.
Other than family history and genetics, the best tool experts have to predict individual breast cancer risk is the Gail model, which takes into account age and number of previous biopsies, as well as family history and pregnancy history.
But, the authors stated, the Gail model is “only slightly better than chance alone.”
This is not the case in cervical or colon cancer, where pathologists can tell from physical characteristics of actual tissue how likely a person is to get that type of cancer.
Breast cancer originates in the breast lobules. The lobules are supposed to disappear as a woman ages, reducing her breast cancer risk, but this doesn’t always happen.
The authors analyzed tissue from 85 women with breast cancer (as well as earlier tissue samples taken before they developed the cancer) and 142 control samples from women who had had benign breast disease.
The more acini per lobule a woman had and the larger the lobule, the higher her risk for developing breast cancer, the researchers found.
This new technique proved more accurate than the Gail model.
The study was a relatively small one by breast cancer standards. More research will not only have to have more women, it will also need to incorporate additional risk factors and will need to be tested in a separate set of women, Radisky said.
Still, he said, the current results “look very good” and he would be “pretty shocked if [more findings] were not consistent.”
If more studies do replicate these initial findings, the procedure might find its way into clinical practice fairly easily and quickly.
“That’s the real power of this. It’s not high tech. It could be done anywhere that takes tissue and has a microscope,” Radisky said. “It could be done anywhere once we build the model, using factors that are available to the physician just from asking the patient and taking tissue, which could be evaluated by any pathologist in any town in America.”
More information
The American Cancer Society has more on risk factors for breast cancer.
By Amanda Gardner
HealthDay Reporter
SOURCES: Derek Radisky, Ph.D., assistant professor, biochemistry, Mayo Clinic, Jacksonville, Fla.; Angela Bradbury, M.D., director, Margaret Dyson Family Risk Assessment Program, Fox Chase Cancer Center, Philadelphia; Oct. 5, 2009, Journal of Clinical Oncology, online
